Skip to main content
Top
Literature
2.
go back to reference Bitto A, Squadrito F, Irrera N, Pizzino G, Pallio G, Mecchio A, Galfo F, Altavilla D. Flavocoxid, a nutraceutical approach to blunt inflammatory conditions. Mediators Inflamm. 2014;2014:790851.CrossRefPubMedPubMedCentral Bitto A, Squadrito F, Irrera N, Pizzino G, Pallio G, Mecchio A, Galfo F, Altavilla D. Flavocoxid, a nutraceutical approach to blunt inflammatory conditions. Mediators Inflamm. 2014;2014:790851.CrossRefPubMedPubMedCentral
3.
go back to reference Altavilla D, Squadrito F, Bitto A, Polito F, Burnett BP, Di Stefano V, Minutoli L. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol. 2009;157(8):1410–8.CrossRefPubMedPubMedCentral Altavilla D, Squadrito F, Bitto A, Polito F, Burnett BP, Di Stefano V, Minutoli L. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol. 2009;157(8):1410–8.CrossRefPubMedPubMedCentral
4.
go back to reference Huang H, Zhou W, Zhu H, Zhou P, Shi X. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicol Appl Pharmacol. 2017;323:36–43.CrossRefPubMed Huang H, Zhou W, Zhu H, Zhou P, Shi X. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicol Appl Pharmacol. 2017;323:36–43.CrossRefPubMed
5.
go back to reference Xu J, Gu W, Li C, Li X, Xing G, Li Y, Song Y, Zheng W. Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha. J Nat Med. 2016;70(3):584–91.CrossRefPubMed Xu J, Gu W, Li C, Li X, Xing G, Li Y, Song Y, Zheng W. Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha. J Nat Med. 2016;70(3):584–91.CrossRefPubMed
6.
go back to reference Pang JY, Zhao KJ, Wang JB, Ma ZJ, Xiao XH. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang Univ Sci B. 2014;15(6):533–9.CrossRefPubMedPubMedCentral Pang JY, Zhao KJ, Wang JB, Ma ZJ, Xiao XH. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang Univ Sci B. 2014;15(6):533–9.CrossRefPubMedPubMedCentral
7.
go back to reference He W, Li LX, Liao QJ, Liu CL, Chen XL. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line. World J Gastroenterol. 2011;17(11):1507–14.CrossRefPubMedPubMedCentral He W, Li LX, Liao QJ, Liu CL, Chen XL. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line. World J Gastroenterol. 2011;17(11):1507–14.CrossRefPubMedPubMedCentral
8.
go back to reference Stonāns I, Stonāne E, Russwurm S, Deigner HP, Böhm KJ, Wiederhold M, Jäger L, Reinhart K. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine. 1999;11(2):151–6.CrossRefPubMed Stonāns I, Stonāne E, Russwurm S, Deigner HP, Böhm KJ, Wiederhold M, Jäger L, Reinhart K. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine. 1999;11(2):151–6.CrossRefPubMed
9.
go back to reference Nikolaidou-Neokosmidou V, Zannis VI, Kardassis D. Inhibition of hepatocytes nuclear factor 4 transcriptional activity by the nuclear factor kappa B pathway. Biochem J. 2006;398(3):439–50.CrossRefPubMedPubMedCentral Nikolaidou-Neokosmidou V, Zannis VI, Kardassis D. Inhibition of hepatocytes nuclear factor 4 transcriptional activity by the nuclear factor kappa B pathway. Biochem J. 2006;398(3):439–50.CrossRefPubMedPubMedCentral
10.
go back to reference Park SG, Ryu HM, Lim SO, Kim YI, Hwang SB, Jung G. Interferon-gamma inhibits hepatitis B virus-induced NF-kappaB activation through nuclear localization of NF-kappaB-inducing kinase. Gastroenterology. 2005;128(7):2042–53.CrossRefPubMed Park SG, Ryu HM, Lim SO, Kim YI, Hwang SB, Jung G. Interferon-gamma inhibits hepatitis B virus-induced NF-kappaB activation through nuclear localization of NF-kappaB-inducing kinase. Gastroenterology. 2005;128(7):2042–53.CrossRefPubMed
11.
go back to reference Chu M, Xu L, Zhang MB, Chu ZY, Wang YD. Role of baicalin in anti-influenza virus A as a potent inducer of IFN-gamma. Biomed Res Int. 2015;2015:263630.PubMedPubMedCentral Chu M, Xu L, Zhang MB, Chu ZY, Wang YD. Role of baicalin in anti-influenza virus A as a potent inducer of IFN-gamma. Biomed Res Int. 2015;2015:263630.PubMedPubMedCentral
12.
go back to reference Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, Liu J, Shi L, Liu C, Wang G, Zou W. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2012;56(4):1342–51.CrossRefPubMed Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, Liu J, Shi L, Liu C, Wang G, Zou W. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2012;56(4):1342–51.CrossRefPubMed
13.
go back to reference Hu G, Xue J, Liu J, Zhang T, Dong H, Duan H, Yang Z, ren X, Mu X. Baicalin baicalin induces IFN-α/β and IFN-γ expressions in cultured mouse pulmonary microvascular endothelial cells. J Integrat Agric. 2012;11(4):646–54.CrossRef Hu G, Xue J, Liu J, Zhang T, Dong H, Duan H, Yang Z, ren X, Mu X. Baicalin baicalin induces IFN-α/β and IFN-γ expressions in cultured mouse pulmonary microvascular endothelial cells. J Integrat Agric. 2012;11(4):646–54.CrossRef
14.
go back to reference Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World J Gastroenterol. 2015;21(15):4644–51.CrossRefPubMedPubMedCentral Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World J Gastroenterol. 2015;21(15):4644–51.CrossRefPubMedPubMedCentral
15.
go back to reference Palumbo GA, Scisciani C, Pediconi N, Lupacchini L, Alfalate D, Guerrieri F, Calvo L, Salerno D, Di Cocco S, Levrero M, Belloni L. IL6 inhibits HBV transcription by targeting the epigenetic control of the nuclear cccDNA minichromosome. PLoS One. 2015;10(11):e0142599.CrossRefPubMedPubMedCentral Palumbo GA, Scisciani C, Pediconi N, Lupacchini L, Alfalate D, Guerrieri F, Calvo L, Salerno D, Di Cocco S, Levrero M, Belloni L. IL6 inhibits HBV transcription by targeting the epigenetic control of the nuclear cccDNA minichromosome. PLoS One. 2015;10(11):e0142599.CrossRefPubMedPubMedCentral
16.
go back to reference Nakamura N, Hayasaka S, Zhang XY, Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res. 2003;77(2):195–202.CrossRefPubMed Nakamura N, Hayasaka S, Zhang XY, Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res. 2003;77(2):195–202.CrossRefPubMed
17.
go back to reference Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, Michalopoulos GK, Stolz DB, Mars WM. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One. 2014;9(4):e96053.CrossRefPubMedPubMedCentral Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, Michalopoulos GK, Stolz DB, Mars WM. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One. 2014;9(4):e96053.CrossRefPubMedPubMedCentral
18.
go back to reference Guo Q, Zhao L, You Q, Yang Y, Gu H, Song G, Lu N, Xin J. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res. 2007;74(1):16–24.CrossRefPubMed Guo Q, Zhao L, You Q, Yang Y, Gu H, Song G, Lu N, Xin J. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res. 2007;74(1):16–24.CrossRefPubMed
20.
go back to reference Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y, Rosenberg W, Dusheiko G, Gilson R, ChinAleong J, Kennedy P, Maini MK. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One. 2012;7(10):e47648.CrossRefPubMedPubMedCentral Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y, Rosenberg W, Dusheiko G, Gilson R, ChinAleong J, Kennedy P, Maini MK. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One. 2012;7(10):e47648.CrossRefPubMedPubMedCentral
21.
go back to reference Ju Y, Hou N, Zhang XN, Zhao D, Liu Y, Wang JJ, Luan F, Shi W, Zhu FL, Sun WS, Zhang LN, Gao CJ, Gao LF, Liang XH, Ma CH. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8 + T cells in a mouse model of hepatitis B virus infection. Cell Mol Immunol. 2009;6(1):35–43.CrossRefPubMedPubMedCentral Ju Y, Hou N, Zhang XN, Zhao D, Liu Y, Wang JJ, Luan F, Shi W, Zhu FL, Sun WS, Zhang LN, Gao CJ, Gao LF, Liang XH, Ma CH. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8 + T cells in a mouse model of hepatitis B virus infection. Cell Mol Immunol. 2009;6(1):35–43.CrossRefPubMedPubMedCentral
Metadata
Title
Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
Publication date
01-03-2018
Published in
Inflammation Research / Issue 3/2018
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-017-1111-x

Other articles of this Issue 3/2018

Inflammation Research 3/2018 Go to the issue